{
    "Trade/Device Name(s)": [
        "Tina-Quant Ceruloplasmin",
        "Ceruloplasmin assay",
        "Roche/Hitachi Tina-Quant Ceruloplasmin"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K091741",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062114"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CHN"
    ],
    "Summary Letter Date": "March 2, 2010",
    "Summary Letter Received Date": "March 10, 2010",
    "Submission Date": "June 10, 2009",
    "Regulation Number(s)": [
        "21CFR866.5210"
    ],
    "Regulation Name(s)": [
        "Ceruloplasmin Immunological Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Ceruloplasmin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Li-heparin Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Roche automated clinical chemistry analyzers",
        "Roche/Hitachi analyzers",
        "Roche Hitachi cobas c systems"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Tina-Quant Ceruloplasmin immunoturbidimetric assay for ceruloplasmin measurement on Roche automated chemistry analyzers",
    "Indications for Use Summary": "In vitro quantitative determination of ceruloplasmin in human serum and plasma to aid in the diagnosis of copper metabolism disorders",
    "fda_folder": "Immunology"
}